Absci Corporation (ABSI) Secures $64M Financing to Drive AI Drug Discovery Through 2028
Absci Corporation (NASDAQ:ABSI), founded in 2018 and headquartered in Seattle, is pioneering the integration of deep learning with high-throughput lab automation to design and optimize biologics at scale...